A Prospective Study of EUS Guided Celiac Block

Completed

Conditions studied: Chronic Pancreatitis, Pancreatic Cancer

In brief

The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.

Key facts

Study ID

NCT00583271

Run by

Indiana University

People needed

127

Starts

2002-06-01

Expected to finish

2012-12-01

Last updated by the study team

2014-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with chronic abdominal pain from documented chronic pancreatitis or pancreatic cancer or other visceral malignancy that are undergoing EUS-guided CB (for purposes other than this study) will be eligible to participate in this study.
• Patients with chronic pancreatitis and pancreatic cancer must have documented disease by CT, ERCP, or EUS.
• No evidence of dementia or altered mental status that would prohibit the giving and understanding of informed consent, and no evidence of psychiatric risk that would preclude adequate compliance with this protocol.
• Patient must provide signed written informed consent

You may not qualify if…

• Patients that have had a previous celiac plexus block are eligible for this study

Where it is running

• Clarian Health: Indiana University Hospital — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.